In the 50 years since it was first introduced, cognitive therapy has been shown to be as efficacious as antidepressant medications (on average) in the acute treatment of nonpsychotic depression, although some patients will do better on one than on the other. Moreover, patients treated to remission with cognitive therapy are less than half as likely to relapse following treatment termination as patients treated to remission with medications. However, a recent study suggests that adding medications interferes with any such enduring effect and medications themselves may have an iatrogenic effect that suppresses symptoms at the expense of prolonging the underlying episode. Neural imaging suggests that cognitive therapy works from the “top down” to facilitate cortical regulation of affect processes whereas medications work from the “bottom up” to dampen the stress response. Adaptationist theory suggests that depression is an evolved adaptation that served to keep our ancestors ruminating about complex social problems until they arrived at a solution; if true then any intervention that facilitates problem solving is likely preferable to one that merely anesthetizes distress.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Alloy, L. B., Abramson, L. Y., Whitehouse, W. G., Hogan, M. E., Panzarella, C., & Rose, D. T. (2006). Prospective incidence of first onsets and recurrences of depression in individuals at high and low cognitive risk for depression. Journal of Abnormal Psychology,115, 145–156. https://doi.org/10.1037/0021-843X.115.1.145.
American Psychiatric Association. (2000). Practice guideline for the treatment of patients with major depressive disorder (revision). American Journal of Psychiatry,157(supplement 4), 1–45.
Andrews, P. W., Bharwani, A., Lee, K. R., Fox, M., & Thomson, J. A., Jr. (2015). Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. Neuroscience and Biobehavioral Reviews,51, 164–188. https://doi.org/10.1016/j.neubiorev.2015.01.018.
Andrews, P. W., Kornstein, S. G., Halberstadt, L. J., Gardner, C. O., & Neale, M. C. (2011). Blue again: Perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. Frontiers in Psychology,2, 159. https://doi.org/10.3389/fpsyg.2011.00159.
Andrews, P. W., & Thomson, J. A., Jr. (2009). The bright side of being blue: Depression as an adaptation for analyzing complex problems. Psychological Review,116, 620–654. https://doi.org/10.1037/a0016242.
Andrews, P. W., Thomson, J. A., Jr., Amstadter, A., & Neale, M. C. (2012). Primum non nocere: An evolutionary analysis of whether antidepressants do more harm than good. Frontiers in Psychology,3, 117. https://doi.org/10.3389/fpsyg.2012.00117.
Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000). Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA,283(19), 2529–2536. https://doi.org/10.1001/jama.283.19.2529.
Barton, D. A., Esler, M. D., Dawood, T., Lambert, E. A., Haikerwal, D., Brenchley, C., et al. (2008). Elevated brain serotonin turnover in patients with depression. Archives of General Psychiatry,65, 38–46. https://doi.org/10.1001/archgenpsychiatry.20007.11.
Bartoskova, M., Sevcikova, M., Durisko, Z., Maslej, M. M., Barbic, S. P., Preiss, M., et al. (2018). The form and function of depressive rumination. Evolution and Human Behavior,39, 277–289. https://doi.org/10.1016/j.evolhumbehav.2018.01.005.
Bateson, M., Brilot, B., & Nettle, D. (2011). Anxiety: An evolutionary approach. The Canadian Journal of Psychiatry,56(12), 707–715. https://doi.org/10.1177/070674371105601202.
Beck, A. T. (1963). Thinking and depression: 1. Idiosyncratic content and cognitive distortions. Archives of General Psychiatry,9, 324–333. https://doi.org/10.1001/archpsyc.1963.01720160014002.
Beck, A. T. (1964). Thinking and depression: 2. Theory and therapy. Archives of General Psychiatry,10, 561–571. https://doi.org/10.1001/archpsyc.1964.01720240015003.
Beck, A. T. (1967). Depression: Clinical, experimental, and theoretical aspects. New York: Hoeber. (Republished as Depression: Causes and treatment. Philadelphia: University of Pennsylvania Press, 1973).
Beck, A. T. (1970). Cognitive therapy: Nature and relation to behavior therapy. Behavior Therapy,1, 184–200. https://doi.org/10.1016/S0005-7894(70)80030-2.
Beck, A. T., & Bredemeier, K. (2016). A unified model of depression: Integrating clinical, cognitive, biological, and evolutionary perspectives. Clinical Psychological Science,4(4), 596–619. https://doi.org/10.1177/2167702616628523.
Beck, A. T., Rush, A. J., Shaw, B. F., & Emery, G. (1979). Cognitive therapy of depression. New York: Guilford Press.
Belmaker, R. H., & Agam, G. (2008). Major depressive disorder. New England Journal of Medicine,358, 55–68. https://doi.org/10.1056/NEJMra073096.
Blackburn, I. M., Bishop, S., Glen, A. I. M., Whalley, L. J., & Christie, J. E. (1981). The efficacy of cognitive therapy in depression: A treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. British Journal of Psychiatry,139, 181–189. https://doi.org/10.1192/bjp.139.3.181.
Blackburn, I. M., Eunson, K. M., & Bishop, S. (1986). A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. Journal of Affective Disorders,10, 67–75. https://doi.org/10.1016/0165-0327(86)90050-9.
Bockting, C., Hollon, S. D., Jarrett, R. B., Kuyken, W., & Dobson, K. (2015). A lifetime approach to Major Depressive Disorder: The contributions of psychological interventions in preventing relapse and recurrence. Clinical Psychology Review,41, 16–26. https://doi.org/10.1016/j.cpr.2015.02.003.
Braun, J. D., Strunk, D. R., Sasso, K. E., & Cooper, A. A. (2015). Therapist use of Socratic questioning predicts session-to-session symptom change in cognitive therapy for depression. Behaviour Research and Therapy,70, 32–37. https://doi.org/10.1016/j.brat.2015.05.004.
Brent, D. A., Brunwasser, S. M., Hollon, S. D., Weersing, V. R., Clarke, G. N., Dickerson, J. F., et al. (2015). Prevention of depression in at-risk adolescents: Impact of a cognitive behavioral prevention program on depressive episodes, depression-free days, and developmental competence 6 years after the intervention. JAMA Psychiatry,72(11), 1110–1118. https://doi.org/10.1001/jamapsychiatry.2015.1559.
Bruijniks, S. J., DeRubeis, R. J., Hollon, S. D., & Huibers, M. J. (2019). The potential role of learning capacity in cognitive behavior therapy for depression: A systematic review of the evidence and future directions for improving therapeutic learning. Clinical Psychological Science,7(4), 668–692. https://doi.org/10.1177/2167702619830391/www.psychologicalscience.org/CPS.
Coffman, S., Martell, C. R., Dimidjian, S., Gallop, R., & Hollon, S. D. (2007). Extreme non-response in cognitive therapy: Can behavioral activation succeed where cognitive therapy fails? Journal of Consulting and Clinical Psychology,75, 531–541. https://doi.org/10.1037/0022-006X.75.4.531.
Cohen, Z. D., & DeRubeis, R. J. (2018). Treatment selection in depression. Annual Review of Clinical Psychology,14, 151–1528. https://doi.org/10.1146/annurev-clinpsy-050817-084746.
Crook, R. J., Dickson, K., Hanlon, R. T., & Walters, E. T. (2014). Nociceptive sensitization reduces predation risk. Current Biology,24, 1121–1125. https://doi.org/10.1016/j.cub.2014.03.043.
Cuijpers, P., Hollon, S. D., van Straten, A., Bockting, C., Berking, M., & Andersson, G. (2013). Does cognitive behavior therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? British Medical Journal Open. https://doi.org/10.1136/bmjopen-2012-002542.
de Catanzaro, D. (1995). Reproductive status, family interactions, and suicidal ideation: Surveys of the general public and high-risk groups. Ethology and Sociobiology,16(5), 385–394. https://doi.org/10.1016/0162-3095(95)00055-0.
DeRubeis, R. J., Cohen, Z. D., Forand, N. R., Fournier, J. C., Gelfand, L. A., & Lorenzo-Luaces, L. (2014). The Personalized Advantage Index: Translating research on prediction into individualized treatment recommendations A demonstration. PLoS ONE,9(1), e83875. https://doi.org/10.1371/journal.pone.0083875.
DeRubeis, R. J., Evans, M. D., Hollon, S. D., Garvey, M. J., Grove, W. M., & Tuason, V. B. (1990). How does cognitive therapy work? Cognitive change and symptom change in cognitive therapy and pharmacotherapy for depression. Journal of Consulting and Clinical Psychology,58, 862–869. https://doi.org/10.1037/0022-006x.58.6.862.
DeRubeis, R. J., & Feeley, M. (1990). Determinants of change in cognitive therapy for depression. Cognitive Therapy and Research,14, 469–482. https://doi.org/10.1007/BF01172968.
DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, P. R., Salomon, R. M., et al. (2005). Cognitive therapy vs. medications in the treatment of moderate to severe depression. Archives of General Psychiatry,62, 409–416. https://doi.org/10.1001/archpsyc.62.4.409.
DeRubeis, R. J., Siegle, G. J., & Hollon, S. D. (2008). Cognitive therapy versus medication for depression: Treatment outcomes and neural mechanisms. Nature Reviews Neuroscience,9, 788–796. https://doi.org/10.1038/nrn2345.
DeRubeis, R. J., Zajecka, J., Shelton, R. C., Amsterdam, J. D., Fawcett, J., Xu, C., et al. (2020). Prevention of recurrence after recovery from a major depressive episode with antidepressant medication alone or in combination with cognitive behavior therapy: Phase 2 of a 2-phase randomized clinical trial. JAMA Psychiatry,77(3), 237–245. https://doi.org/10.1001/jamapsychiatry.2019.3900.
Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., et al. (2006). Behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of major depression. Journal of Consulting and Clinical Psychology,74, 658–670. https://doi.org/10.1037/0022-006X.74.4.658.
Dobson, K. S., Hollon, S. D., Dimidjian, S., Schmaling, K. B., Kohlenberg, R. J., Gallop, R. J., et al. (2008). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. Journal of Consulting and Clinical Psychology.,76, 468–477. https://doi.org/10.1037/0022-006X.76.3.468.
Driessen, E., Cuijpers, P., Hollon, S. D., & Dekker, J. J. M. (2010). Does pretreatment severity moderate the efficacy of psychological treatment of adult outpatient depression? A meta-analysis. Journal of Consulting and Clinical Psychology,78, 668–680. https://doi.org/10.1037/a0020570.
Elkin, I., Gibbons, R. D., Shea, M. T., Sotsky, S. M., Watkins, J. T., Pilkonis, P. A., et al. (1995). Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Journal of Consulting and Clinical Psychology,63, 841–847. https://doi.org/10.1037//0022-006x.63.5.841.
Elkin, I., Shea, M. T., Watkins, J. T., Imber, S. D., Sotsky, S. M., Collins, J. F., et al. (1989). National Institute of Mental Health Treatment of Depression Collaborative Research Program: General effectiveness of treatments. Archives of General Psychiatry,46, 971–982. https://doi.org/10.1001/archpsyc.1989.01810110013002.
Evans, M. D., Hollon, S. D., DeRubeis, R. J., Piasecki, J. M., Grove, W. M., Garvey, M. J., et al. (1992). Differential relapse following cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry,49, 802–808. https://doi.org/10.1001/archpsy.1992.01820100046009.
Evans, J. S. B. T., & Stanovich, K. E. (2013). Dual-process theories of higher cognition: Advancing the debate. Perspectives on psychological science, 8(3), 223–241.
Feeley, M., DeRubeis, R. J., & Gelfand, L. A. (1999). The temporal relation of adherence and alliance to symptom change in cognitive therapy for depression. Journal of Consulting and Clinical Psychology,67, 578–582. https://doi.org/10.1037//0022-006x.67.4.578.
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., et al. (2013). Burden of depressive disorders by country, sex, age, and year: Findings from the Global Burden of Disease Study 2010. PLoS Medicine,10(11), e1001547. https://doi.org/10.1371/journal.pmed.1001547.
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., et al. (2010). Antidepressant drug effects and depression severity: A patient-level meta-analysis. JAMA,303, 47–53. https://doi.org/10.1001/jama.2009.1943.
Fournier, J. C., DeRubeis, R. J., Shelton, R. C., Gallop, R., Amsterdam, J. D., & Hollon, S. D. (2008). Antidepressant medications versus cognitive therapy in depressed patients with or without personality disorder. British Journal of Psychiatry,192, 124–129. https://doi.org/10.1192/bjp.bp.107.037234.
Fournier, J. C., DeRubeis, R. J., Shelton, R. C., Hollon, S. D., Amsterdam, J. D., & Gallop, R. (2009). Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. Journal of Consulting and Clinical Psychology,77, 775–787. https://doi.org/10.1037/a0015401.
Frank, E., Prien, R. F., Jarrett, R. B., Keller, M. B., Kupfer, D. J., Lavori, P. W., et al. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorders: Remission, recovery, relapse, and recurrence. Archives of General Psychiatry,48, 851–855.
Garber, J., Clarke, G. N., Weersing, V. R., Beardslee, W. R., Brent, D. A., Gladstone, T. R. G., et al. (2009). Prevention of depression in at-risk adolescents: A randomized controlled trial. JAMA,301, 2215–2224. https://doi.org/10.1001/jama.2009.788.
Goldapple, K., Segal, Z., Garson, C., Lau, M., Bieling, P., Kennedy, S., et al. (2004). Modulation of cortical-limbic pathways in major depression: Treatment-specific effects of cognitive behavior therapy. Archives of General Psychiatry,61, 34–41. https://doi.org/10.1001/archpsyc.61.1.34.
Gray, J. A. (1990). Brain systems that mediate both emotion and cognition. Cognition and Emotion,4, 269–288. https://doi.org/10.1080/02699939008410799.
Hamilton, W. (1964). The genetical evolution of social behaviour I. Journal of Theoretical Biology,7(1), 1–16. https://doi.org/10.1016/0022-5193(64)90038-4.
Hebb, D. O. (1949). The organization of behavior: A neuropsychological theory. New York: Wiley.
Hollon, S. D., & Beck, A. T. (1979). Cognitive therapy of depression. In P. C. Kendall & S. D. Hollon (Eds.), Cognitive-behavioral interventions: Theory, research, and procedures (pp. 153–203). New York: Academic Press.
Hollon, S. D., DeRubeis, R. J., & Evans, M. D. (1996). Cognitive therapy in the treatment and prevention of depression. In P. M. Salkovskis (Ed.), Frontiers of cognitive therapy (pp. 293–317). New York: Guilford Press.
Hollon, S. D., DeRubeis, R. J., Evans, M. D., Wiemer, M. J., Garvey, M. J., Grove, W. M., et al. (1992). Cognitive therapy, pharmacotherapy and combined cognitive-pharmacotherapy in the treatment of depression. Archives of General Psychiatry,49, 774–781. https://doi.org/10.1016/S096-1849(05)80149-0.
Hollon, S. D., DeRubeis, R. J., Fawcett, J., Amsterdam, J. D., Shelton, R. C., Zajecka, J., et al. (2014). Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: A randomized clinical trial. JAMA Psychiatry,71(10), 1157–1164. https://doi.org/10.1001/jamapsychiatry.2014.1054.
Hollon, S. D., DeRubeis, R. J., Shelton, R. C., Amsterdam, J. D., Salomon, R. M., O’Reardon, J. P., et al. (2005a). Prevention of relapse following cognitive therapy versus medications in moderate to severe depression. Archives of General Psychiatry,62, 417–422. https://doi.org/10.1001/archpsyc.62.4.417.
Hollon, S. D., & Garber, J. (1990). Cognitive therapy of depression: A social-cognitive perspective. Personality and Social Psychology Bulletin,16, 58–73. https://doi.org/10.1177/0146167290161005.
Hollon, S. D., Jarrett, R. B., Nierenberg, A. A., Thase, M. E., Trivedi, M., & Rush, A. J. (2005b). Psychotherapy and medication in the treatment of adult and geriatric depression: Which monotherapy or combined treatment? Journal of Clinical Psychiatry,66, 455–468. https://doi.org/10.4088/jcp.v66n0408.
Joiner, T. E., Pettit, J. W., Walker, R. L., Voelz, Z. R., Cruz, J., Rudd, M. D., et al. (2002). Perceived burdensomeness and suicidality: Two studies on the suicide notes of those attempting and those completing suicide. Journal of Social and Clinical Psychology,21(5), 531–545. https://doi.org/10.1521/jscp.21.5.531.22624.
Kahneman, D. (2011). Thinking, fast and slow. New York: Farrar, Straus, and Giroux.
Kazdin, A. E. (2007). Mediators and mechanisms of change in psychotherapy research. Annual Review of Clinical Psychology,3, 1–27. https://doi.org/10.1146/annurev.clinpsy.3.022806.091432.
Keller, M. C. (2018). Evolutionary perspectives on genetic and environmental risk factors for psychiatric disorders. Annual Review of Clinical Psychology,14, 471–493. https://doi.org/10.1146/annurev-clinpsy-050817-084854.
Keller, M. C., & Miller, G. (2006). Resolving the paradox of common, harmful, heritable mental disorders: Which evolutionary genetic models work best? Behavioral and Brain Sciences,29, 385–452. https://doi.org/10.1017/S0140525X06009095.
Kennedy, S. H., Konarski, J. Z., Segal, Z. V., Lau, M. A., Bieling, P. J., McIntyre, R. S., et al. (2007). Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. American Journal of Psychiatry,164, 778–788. https://doi.org/10.1176/ajp.2007.164.5.778.
Kovacs, M., Rush, A. J., Beck, A. T., & Hollon, S. D. (1981). Depressed outpatients treated with cognitive therapy or pharmacotherapy: A one-year follow-up. Archives of General Psychiatry,38, 33–39. https://doi.org/10.1001/archpsyc.1981.01780260035003.
Klein, D. F. (1996). Preventing hung juries about therapy studies. Journal of Consulting and Clinical Psychology,64, 74–80. https://doi.org/10.1037/0022-006X.64./1.81.
Lewis, R. (1974). Accidental career. New Scientist,63, 322–325.
Leykin, Y., Amsterdam, J. D., DeRubeis, R. J., Gallop, R., Shelton, R. C., & Hollon, S. D. (2007). Progressive resistance to selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. Journal of Consulting and Clinical Psychology,75, 267–276. https://doi.org/10.1037/0022-006X.75.2.267.
Luoma, J. B., & Pearson, J. L. (2002). Suicide and marital status in the United States, 1991–1996: Is widowhood a risk factor? American Journal of Public Health,92(9), 1518–1522. https://doi.org/10.1176/appi.ajp.159.6.909.
Maier, S. F., Amat, J., Baratta, M. V., Paul, E., & Watkins, L. R. (2006). Behavioral control, the medial prefrontal cortex, and resilience. Dialogues in Clinical Neuroscience,8, 353–373.
Maier, S. F., & Seligman, M. E. P. (2016). Learned helplessness at fifty: Insights from neuroscience. Psychological Review,123, 349–367. https://doi.org/10.1037/rev0000033.
Maslej, M. M., Rheaume, A. R., Schmidt, L. A., & Andrews, P. W. (2019). Using expressive writing to test an evolutionary hypothesis about depressive rumination: Sadness coincides with causal analysis of a personal problem, not problem-solving analysis. Evolutionary Psychological Science. https://doi.org/10.1007/s40806-019-00219-8.
Mayberg, H. S. (2009). Targeted electrode-based modulation of neural circuits for depression. Journal of Clinical Investigation,119, 717–725. https://doi.org/10.1172/JCI38454.
Mayberg, H. S., Brannan, S. K., Tekell, J. L., Silva, J. A., Mahurin, R. K., McGinnis, S., et al. (2000). Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response. Biological Psychiatry,48, 830–843. https://doi.org/10.1016/s0006-3223(00)01036-2.
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., et al. (2005). Deep brain stimulation for treatment-resistant depression. Neuron,45, 651–660. https://doi.org/10.1016/j.neuron.2005.02.014.
McGrath, C. L., Kelley, M. E., Holtzheimer, P. E., Dunlop, B. W., Craighead, W. E., Franco, A. R., et al. (2013). Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry,70(8), 821–829. https://doi.org/10.1001/jamapsychiatry.2013.143.
Miller, W. R. (1975). Psychological deficit in depression. Psychological Bulletin,82, 238–260. https://doi.org/10.1037/h0076367.
Monroe, S. M., Anderson, S. F., & Harkness, K. L. (2019). Life stress and major depression: The mysteries of recurrences. Psychological Review,126, 791–816. https://doi.org/10.1037/rev0000157.
Murphy, G. E., Simons, A. D., Wetzel, R. D., & Lustman, P. J. (1984). Cognitive therapy and pharmacotherapy, singly and together, in the treatment of depression. Archives of General Psychiatry,41, 33–41. https://doi.org/10.1001/archpsyc.1984.01790120037006.
Nademin, E., Jobes, D. A., Pflanz, S. E., Jacoby, A. M., Ghahramanlou-Holloway, M., Campise, R., et al. (2008). An investigation of interpersonal-psychological variables in Air Force suicides: A controlled-comparison study. Archives of Suicide Research,12(4), 309–326. https://doi.org/10.1080/13811110802324847.
Nesse, R. M. (2000). Is depression an adaptation? Archives of General Psychiatry,57, 14–20. https://doi.org/10.1001/archpsyc.57.1.14.
Nesse, R. M. (2005a). Natural selection and the regulation of defenses: A signal detection analysis of the smoke detector principle. Evolution and human behavior,26(1), 88–105. https://doi.org/10.1016/j.evolhumbehav.2004.08.002.
Nesse, R. M. (2005b). An evolutionary framework for understanding grief. In D. S. Carr, R. M. Nesse, & C. B. Wortman (Eds.), Late life widowhood in the United States: Spousal bereavement in late life (pp. 195–226). New York: Springer.
Nolen-Hoeksema, S. (2012). Emotion regulation and psychopathology: The role of gender. Annual Review of Clinical Psychology,8, 161–187. https://doi.org/10.1146/annurev-clinpsy-032511-143109.
Roese, N. J., & Epstude, K. (2017). The functional theory of counterfactual thinking: New evidence, new challenges, new insights. Advances in experimental social psychology (pp. 1–79). New York: Academic Press.
Rush, A. J., Beck, A. T., Kovacs, M., & Hollon, S. D. (1977). Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. Cognitive Therapy and Research,1, 17–38. https://doi.org/10.1007/BF01173502.
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., et al. (2006). Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology,31, 1841–1853. https://doi.org/10.1038/sj.npp.1301131.
Salkovskis, P. M. (1996). The cognitive approach to anxiety: Threat beliefs, safety seeking behaviour and the special case of health anxiety and obsessions. In P. Salkovskis (Ed.), Frontiers of cognitive therapy. New York: Guilford Press.
Simons, A. D., Murphy, G. E., Levine, J. E., & Wetzel, R. D. (1986). Cognitive therapy and pharmacotherapy for depression: Sustained improvement over one year. Archives of General Psychiatry,43, 43–49. https://doi.org/10.1001/archpsyc.1986.01800010045006.
Strunk, D. R., DeRubeis, R. J., Chiu, A. W., & Alvarez, J. (2007). Patients’ competence in and performance of cognitive therapy skills: Relation to the reduction of relapse risk following treatment for depression. Journal of Consulting and Clinical Psychology,75, 523–530. https://doi.org/10.1037/0022-0006X.75.4.523.
Tang, T. Z., DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., & Shelton, R. C. (2007). Sudden gains in cognitive therapy of depression and relapse/recurrence. Journal of Consulting and Clinical Psychology,75, 404–408. https://doi.org/10.1037/0022-006X.75.3.04.
Tooby, J., & Cosmides, L. (1990). The past explains the present: Emotional adaptations and the structure of ancestral environments. Ethology and Sociobiology,11(4–5), 375–424. https://doi.org/10.1016/0162-3095(90)90017-Z.
Volk, A. A., & Atkinson, J. A. (2013). Infant and child death in the human environment of evolutionary adaptation. Evolution and Human Behavior,34(3), 182–192. https://doi.org/10.1016/j.evolhumbehav.2012.11.007.
West, S. A., & Gardner, A. (2013). Adaptation and inclusive fitness. Current Biology,23(13), R577–R584. https://doi.org/10.1016/j.cub.2013.05.031.
Conflict of Interest
Steven D. Hollon, Robert J. DeRubeis, Paul W. Andrews and J. Anderson Thomson, Jr. declare that they have no conflict of interest.
No animal studies were carried out by the authors for this article.
Informed consent was obtained from all individual participants in this study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hollon, S.D., DeRubeis, R.J., Andrews, P.W. et al. Cognitive Therapy in the Treatment and Prevention of Depression: A Fifty-Year Retrospective with an Evolutionary Coda. Cogn Ther Res (2020). https://doi.org/10.1007/s10608-020-10132-1
- Cognitive therapy
- Enduring effects
- Antidepressant medications
- Iatrogenic effects
- Evolved adaptation